Our Story

People often ask whether AI will eventually replace distribution sales, especially after seeing how advanced forecasting systems and automation have become. I always think back to the COVID-19 pandemic, the greatest supply chain disruption our industry had experienced in decades and why that period proved exactly why relationships still matter more than algorithms alone.

During the pandemic, medical device manufacturers across the world were struggling to secure basic operational supplies: IPA, gloves, masks, wipes, cleanroom consumables, and other PPE materials. Global factories were shutting down, governments imposed export restrictions, lead times became unpredictable, and suppliers were allocating products overnight. Systems and forecasts became almost meaningless because historical demand patterns no longer applied.

Many companies waited for data to stabilize. In distribution sales, we did not have that luxury.

For more than 25 years, our business had been built on relationships; not only with customers, but with manufacturers, logistics providers, plant managers, procurement teams, and supplier leadership around the world. During COVID, those relationships became more valuable than any software platform.

While others were sending automated shortage notifications, we were on calls late into the night coordinating inventory across multiple regions, identifying alternative sources, and working collaboratively with customers to prioritize critical manufacturing operations. Sometimes the solution came from conversations no system could predict: a supplier willing to release partial inventory because of years of partnership, a customer sharing production forecasts honestly so we could allocate fairly, or a logistics partner finding creative ways to move restricted materials across borders.

There were moments when customers called simply because no one else would answer the phone with real information. They did not need another Excel file or dashboard. They needed accountability, transparency, and someone willing to navigate uncertainty alongside them.

Despite worldwide disruptions, restrictions, and delays on the very products everyone was fighting to obtain, we grew our business by more than 70% during that period. Not because products suddenly became easier to source, but because relationships became the deciding factor. Customers remembered who communicated honestly, who stayed engaged under pressure, and who found solutions when traditional systems failed.

AI can analyze inventory trends, optimize routing, and improve forecasting efficiency. But during COVID, success did not come from historical data models because history offered no roadmap. Success came from trust, judgment, collaboration, and decades of relationships that allowed people to work together during impossible conditions.

And when the crisis finally stabilized, the most important result was not only business growth. The strongest outcome was that the partnerships became deeper than transactions. Customers no longer viewed us as simply a distributor. We had become a strategic extension of their operation.

That is why I believe AI will strengthen the distribution model, but it will not replace the human side of it. In medical device manufacturing, especially during moments of uncertainty, relationships are still the most valuable supply chain asset of all.

In the distribution sales model, especially within medical device manufacturing, the true value has never been simply moving products. The value is becoming a trusted extension of the customer’s operation, understanding risks before they become problems, aligning people toward solutions, and strengthening partnerships through difficult moments.